You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Klatskin Tumor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hilar Cholangiocarcinoma Trial in Groningen (Bevacizumab-IRDye800CW, near infrared (NIR) fluorescence imaging)

Recruiting
  • Hilar Cholangiocarcinoma
  • Groningen, Netherlands
    University Medical Center Groningen
Apr 27, 2021

Hilar Cholangiocarcinoma Trial in Xuzhou (I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech,

Enrolling by invitation
  • Hilar Cholangiocarcinoma
  • I-125 seeds loaded stent (self-expanded metal stent with I-125 seeds, Micro-Tech, Nanjing, China)
  • Normal stent (self-expanded metal stent without I-125 seeds, Micro-Tech, Nanjing, China)
  • Xuzhou, Jiangsu, China
    Xuzhou Central Hospital
Jul 12, 2021

Unresectable Hilar Cholangiocarcinoma Trial in Nanjing (REMS+TAI, SEMS+TAI)

Not yet recruiting
  • Unresectable Hilar Cholangiocarcinoma
  • REMS+TAI
  • SEMS+TAI
  • Nanjing, Jiangsu, China
    Zhongda Hospital,Southeast University
Mar 15, 2021

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Cholangiocarcinoma, Perihilar, Surgery Trial in Wuhan (Three dimensional laparoscopic resection for pCCA, Open resection for

Recruiting
  • Cholangiocarcinoma, Perihilar
  • Surgery
  • Three dimensional laparoscopic resection for pCCA
  • Open resection for pCCA
  • Wuhan, Hubei, China
  • +1 more
Oct 5, 2020

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Portal Vein Occlusion, Cholangiocarcinoma, Perihilar, Hepatocellular Carcinoma Trial in Shanghai (PVE with coils plus TAGM, PVE

Recruiting
  • Portal Vein Occlusion
  • +3 more
  • PVE with coils plus TAGM
  • PVE with multiple coils
  • Shanghai, Shanghai, China
    Easter hepatobiliary surgery hospital
Jun 15, 2020

Cholangitis Trial in Lanzhou (ERCP Drainage, PTBD Drainage)

Completed
  • Cholangitis
  • ERCP Drainage
  • PTBD Drainage
  • Lanzhou, Gansu, China
    Hepatopancreatobiliary Surgery Institute of Gansu Province
Jul 10, 2019

Long-term Morbidity After Surgery for Perihilar

Completed
  • Cholangiocarcinoma
  • Surgery--Complications
  • Resection of perihilar cholangiocarcinoma
  • (no location specified)
Jun 26, 2019

Hilar Cholangiocarcinoma Trial in Xi'an (bilateral metal stent insertion, unilateral metal stent insertion)

Unknown status
  • Hilar Cholangiocarcinoma
  • bilateral metal stent insertion
  • unilateral metal stent insertion
  • Xi'an, Shanxi, China
    Han Guo Hong
Jul 31, 2019

Biliary Obstructive Disease Such as Choledocholithiasis, Benign Biliary Stricture, Peri-ampullary Cancer Trial in Seoul

Unknown status
  • Biliary Obstructive Disease Such as Choledocholithiasis
  • +4 more
  • Pacetin® (cefoxitin)
  • Placebo
  • Seoul, Korea, Republic of
    Yonsei university of medical center
Jan 15, 2019

Hilar Cholangiocarcinoma Trial in Guangzhou, Nanjing, Shanghai (PDT-Deuteporfin(6 hour), PDT-Deuteporfin(9 hour), stenting)

Terminated
  • Hilar Cholangiocarcinoma
  • PDT-Deuteporfin（6 hour)
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Jul 15, 2019

Choledocholithiasis, Bile Duct Diseases, Bile Duct Carcinoma Trial in Charlottesville ("Air" contrast cholangiography using

Active, not recruiting
  • Choledocholithiasis
  • +2 more
  • "Air" contrast cholangiography using carbon dioxide gas
  • Charlottesville, Virginia
    University of Virginia Health System
Jun 5, 2022

Liver Cancer, Liver Tumor, Hepatocellular Carcinoma Trial in Tampa

Enrolling by invitation
  • Liver Cancer
  • +3 more
    • Tampa, Florida
      Florida Hospital Tampa
    Nov 9, 2018

    Jaundice, Obstructive, Klatskin Tumor Trial (PTBD group, ENBD group, EBS group)

    Unknown status
    • Jaundice, Obstructive
    • Klatskin Tumor
    • PTBD group
    • +2 more
    • (no location specified)
    Jun 1, 2018

    Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)

    Active, not recruiting
    • Cholangiocarcinoma
    • Fimaporfin and Gemcitabine
    • Gemcitabine/Cisplatin chemotherapy
    • Duarte, California
    • +49 more
    Mar 4, 2022

    Hilar Cholangiocarcinoma Trial in Worldwide (Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen)

    Terminated
    Has Results
    • Hilar Cholangiocarcinoma
    • Photodynamic therapy-Photofrin
    • +2 more
    • Goodyear, Arizona
    • +30 more
    Aug 14, 2019

    Three-dimensional Visualization on Operation Strategy and

    Unknown status
    • Hilar Cholangiocarcinoma
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      Apr 17, 2018

      Unknown Primary Tumors, Oropharynx Cancer Trial in Groningen (Detection of lesions using fluorescence molecular imaging)

      Recruiting
      • Unknown Primary Tumors
      • Oropharynx Cancer
      • Detection of lesions using fluorescence molecular imaging
      • Groningen, Netherlands
        University Medical Center Groningen
      Oct 20, 2023

      Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

      Recruiting
      • Oncology
      • moderate Whole Body Hyperthermia (mWBH)
      • Berlin, Germany
        Klinik für Radioonkologie und Strahlentherapie
      Apr 6, 2023

      Immune Biomarker Study for Salivary Gland Carcinoma

      Not yet recruiting
      • Salivary Gland Tumor
      • Benign Salivary Gland Tumor
      • Sampling
      • Erlangen, Bavaria, Germany
      • +1 more
      Sep 21, 2023

      Advanced Solid Tumor Trial (HS-20093)

      Not yet recruiting
      • Advanced Solid Tumor
      • (no location specified)
      Oct 29, 2023

      Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

      Recruiting
      • Malignant Tumor
      • +2 more
      • 68Ga-TCR-FAPI PET/CT
      • Beijing, China
        Peking University Cancer Hospital
      Oct 19, 2023

      Meningioma, Refractory Meningioma, Relapsed Meningioma Trial in Omaha (ONC201)

      Not yet recruiting
      • Meningioma
      • +2 more
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Aug 21, 2023

      Body Composition and Digestive System Cancer Survival

      Active, not recruiting
      • Digestive System Cancer
        • Nanjing, Jiangsu, China
          The First Affiliated Hospital of Nanjing Medical University
        Sep 19, 2023